In addition, elevated surrogate markers of ICAM-1 and Lp(a) level were more likely to be present in patients with NAFLD with OR 14.53 and 27.22, respectively (p = 0.011 and p = 0.001). Here, ICAM1 is linked to metabolic dysfunction-associated steatotic liver disease.